The Cooper (BSP:C1OO34) Research & Development : R$822 Mil (TTM As of Oct. 2024)

View and export this data going back to 2020. Start your Free Trial

What is The Cooper Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. The Cooper's Research & Development for the three months ended in Oct. 2024 was R$212 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Oct. 2024 was R$822 Mil.

The Cooper Research & Development Historical Data

The historical data trend for The Cooper's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Research & Development Chart

The Cooper Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Research & Development

Get a 7-Day Free Trial

524.84

513.71

579.31

694.68

872.87

The Cooper Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Research & Development	Get a 7-Day Free Trial															185.55	194.27	199.56	216.21	212.17

The Cooper Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$822 Mil.

The Cooper (BSP:C1OO34) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

The Cooper Research & Development Related Terms

Thank you for viewing the detailed overview of The Cooper's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

The Cooper Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (BSP:C1OO34) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

COO:USA COO:Mexico 0I3I:UK CP60:Germany CP60:Germany

Address

6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583

Website

https://www.coopercos.com

CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.

The Cooper Headlines

No Headlines